Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders
Clinical trial NCT02929823 · COMPLETED
Trial details
- NCT number
- NCT02929823
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-05-03
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.